Targeting interlukin-6 to relieve immunosuppression in tumor microenvironment
Author:
Affiliation:
1. Department of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
2. Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
Publisher
IOS Press
Subject
General Medicine
Link
http://journals.sagepub.com/doi/pdf/10.1177/1010428317712445
Reference139 articles.
1. Inflammation and cancer
2. The roles of mesenchymal stem cells in tumor inflammatory microenvironment
3. Phenotype, function and clinical implications of myeloid-derived suppressor cells in cancer patients
4. Inflammation Induces Myeloid-Derived Suppressor Cells that Facilitate Tumor Progression
5. Targeting and utilizing primary tumors as live vaccines: changing strategies
Cited by 51 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Aryl azoles based scaffolds for disrupting tumor microenvironment;Bioorganic & Medicinal Chemistry;2023-11
2. Targeting the STAT3 oncogenic pathway: Cancer immunotherapy and drug repurposing;Biomedicine & Pharmacotherapy;2023-11
3. Interleukin-6-controlled, mesenchymal stem cell-based sodium/iodide symporter gene therapy improves survival of glioblastoma-bearing mice;Molecular Therapy - Oncolytics;2023-09
4. The immune escape mechanism of nasopharyngeal carcinoma;The FASEB Journal;2023-06-26
5. IL-6 is dispensable for causing cachexia in the colon carcinoma 26 model;2023-05-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3